Literature DB >> 29032561

Pathology and Pathobiology of Pulmonary Hypertension.

Christophe Guignabert1,2, Peter Dorfmüller1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29032561     DOI： 10.1055/s-0037-1606214

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN： 1069-3424            Impact factor:   3.119


× No keyword cloud information.
  11 in total

Review 1.  Nets, pulmonary arterial hypertension, and thrombo-inflammation.

Authors:  Luís Pedro Baptista de Barros Ribeiro Dourado; Mário Santos; Daniel Moreira-Gonçalves
Journal:  J Mol Med (Berl)       Date:  2022-04-20       Impact factor: 4.599

Review 2.  CD39 in the development and progression of pulmonary arterial hypertension.

Authors:  Abbey Willcox; Natasha Ting Lee; Harshal H Nandurkar; Maithili Sashindranath
Journal:  Purinergic Signal       Date:  2022-08-10       Impact factor: 3.950

3.  SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension.

Authors:  Yufeng Yao; Hui Li; Xinwen Da; Zuhan He; Bo Tang; Yong Li; Changqing Hu; Chengqi Xu; Qiuyun Chen; Qing K Wang
Journal:  Pulm Pharmacol Ther       Date:  2019-01-28       Impact factor: 3.410

Review 4.  Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update.

Authors:  James C Coons; Kristen Pogue; Andrew R Kolodziej; Glenn A Hirsch; Marjorie Patricia George
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

5.  A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism.

Authors:  Carly Jones; Malik Bisserier; Carlos Bueno-Beti; Guillaume Bonnet; Susana Neves-Zaph; Sang-Yong Lee; Javier Milara; Peter Dorfmüller; Marc Humbert; Jane A Leopold; Lahouaria Hadri; Roger J Hajjar; Yassine Sassi
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

6.  Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.

Authors:  Fangwei Li; Dan Wang; Hong Wang; Lijun Chen; Xilu Sun; Yixin Wan
Journal:  Respir Res       Date:  2021-08-31

Review 7.  An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension.

Authors:  Weifang Zhang; Zeying Tao; Fei Xu; Qian Diao; Juan Li; Lu Zhou; Yaxin Miao; Shanshan Xie; Jinjin Wan; Ruilai Xu
Journal:  Biomed Res Int       Date:  2021-10-07       Impact factor: 3.411

8.  Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy.

Authors:  Suchi Chang; Jian Wu; Jifu Jin; Huairui Shi; Rifeng Gao; Xiao Li; Daile Jia; Xiaolei Sun; Tiantong Ou; Ji'e Yang; Aijun Sun; Junbo Ge
Journal:  Oxid Med Cell Longev       Date:  2022-06-20       Impact factor: 7.310

9.  rBMSC/Cav-1F92A Mediates Oxidative Stress in PAH Rat by Regulating SelW/14-3-3η and CA1/Kininogen Signal Transduction.

Authors:  Wan-Cheng Yu; Hai-Ying Chen; Hong-Li Yang; Peng Xia; Cheng-Wei Zou; Tong-Wen Sun; Le-Xin Wang
Journal:  Stem Cells Int       Date:  2019-10-28       Impact factor: 5.443

Review 10.  Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?

Authors:  Ayse Ceren Mutgan; Katharina Jandl; Grazyna Kwapiszewska
Journal:  Cells       Date:  2020-09-03       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.